Hypera S.A., which operates as Hypera Pharma, is a Brazilian pharmaceutical company focused on the domestic market. The company is dedicated to the development, production and sale of a wide portfolio of pharmaceutical products, with a presence in almost every point of sale in Brazil. Its operations cover all pharmaceutical retail segments, with a portfolio of leading brands highlighted. The company also operates in the Institutional Market, which includes public sector sales. The business model is supported by investments in innovation, new product launches in its business units, and the expansion of production capacity. The company invests in the production of strategic inputs and in new plants for products such as oncology and biologics to support its growth. Fonts
How many years of EBITDA are required to pay off the company's net debt, according to the official accounting standard IFRS16. As a market consensus, a value of up to 3 years of leverage is accepted for most companies.
How much the company's debt represents in % in relation to its equity. As a market consensus, a value less than or equal to 1 is accepted, above that leverage can end up hurting the final result at some point.
...and much more!